PH12016500497B1 - Compositions for the treatment of hypertension and/or fibrosis - Google Patents
Compositions for the treatment of hypertension and/or fibrosis Download PDFInfo
- Publication number
- PH12016500497B1 PH12016500497B1 PH12016500497A PH12016500497A PH12016500497B1 PH 12016500497 B1 PH12016500497 B1 PH 12016500497B1 PH 12016500497 A PH12016500497 A PH 12016500497A PH 12016500497 A PH12016500497 A PH 12016500497A PH 12016500497 B1 PH12016500497 B1 PH 12016500497B1
- Authority
- PH
- Philippines
- Prior art keywords
- fibrosis
- compound
- present
- treatment
- hypertension
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C235/32—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton containing six-membered aromatic rings
- C07C235/34—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton containing six-membered aromatic rings having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/09—Geometrical isomers
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2013903573A AU2013903573A0 (en) | 2013-09-17 | Compositions for the treatment of hypertension and/or fibrosis | |
| PCT/AU2014/000923 WO2015039173A1 (en) | 2013-09-17 | 2014-09-17 | Compositions for the treatment of hypertension and/or fibrosis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| PH12016500497A1 PH12016500497A1 (en) | 2016-06-13 |
| PH12016500497B1 true PH12016500497B1 (en) | 2017-12-13 |
Family
ID=52687998
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PH12016500497A PH12016500497B1 (en) | 2013-09-17 | 2016-03-14 | Compositions for the treatment of hypertension and/or fibrosis |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US9458093B2 (https=) |
| EP (1) | EP3046901B1 (https=) |
| JP (1) | JP6122548B2 (https=) |
| KR (1) | KR101736416B1 (https=) |
| CN (1) | CN105683152B (https=) |
| AP (1) | AP2016009079A0 (https=) |
| AU (1) | AU2014324078B2 (https=) |
| BR (1) | BR112016005601B1 (https=) |
| CA (1) | CA2924356C (https=) |
| DK (1) | DK3046901T3 (https=) |
| ES (1) | ES2655455T3 (https=) |
| IL (1) | IL244621A (https=) |
| MX (1) | MX368865B (https=) |
| MY (1) | MY172557A (https=) |
| NO (1) | NO3046901T3 (https=) |
| NZ (1) | NZ717927A (https=) |
| PH (1) | PH12016500497B1 (https=) |
| PL (1) | PL3046901T3 (https=) |
| RU (1) | RU2635564C2 (https=) |
| SG (1) | SG11201601642WA (https=) |
| UA (1) | UA118111C2 (https=) |
| WO (1) | WO2015039173A1 (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3284981B2 (ja) | 1998-11-02 | 2002-05-27 | 株式会社デンソー | 車両用交流発電機およびそのステータの製造方法 |
| US9956166B2 (en) | 2013-09-18 | 2018-05-01 | Sorrento Therapeutics, Inc. | Methods for administration and methods for treating cardiovascular diseases with resiniferatoxin |
| MX376504B (es) | 2015-03-18 | 2025-03-07 | Vectus Biosystems Ltd | Composiciones para el tratamiento de enfermedades renales y/o hepaticas. |
| DK3271320T3 (da) * | 2015-03-18 | 2020-02-03 | Vectus Biosystems Ltd | Sammensætninger til behandling af fibrose og fibroserelaterede tilstande |
| EP3353147B1 (en) * | 2015-09-22 | 2021-01-13 | Vectus Biosystems Limited | Synthesis of terphenyl compounds |
| IL298314B2 (en) * | 2016-04-13 | 2025-04-01 | Univ Nebraska | Methods of administration and methods of treating cardiovascular diseases with resiniparatoxin |
| BR112019001510B1 (pt) * | 2016-07-28 | 2022-11-08 | Vectus Biosystems Limited | Composto, e, uso de um composto para manufatura de um medicamento para tratar profilática ou terapeuticamente fibrose pulmonar, ou uma enfermidade relacionada em um indivíduo com fibrose pulmonar ou em risco de desenvolver fibrose pulmonar |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2694288B1 (fr) * | 1992-06-30 | 1994-09-09 | Rhone Poulenc Agrochimie | Phenylbenzamides fongicides et procédés pour les préparer. |
| ES2523659T3 (es) * | 2004-06-11 | 2014-11-28 | Vectus Biosystems Limited | Composiciones y procedimientos para el tratamiento de enfermedades cardiovasculares |
| NZ623674A (en) * | 2005-12-09 | 2014-07-25 | Vectus Biosystems Ltd | Vip fragments and methods of use |
| US20120088737A2 (en) * | 2009-10-02 | 2012-04-12 | Ajinomoto Co., Inc | Novel acyl guanidine derivatives |
| JP6293266B2 (ja) * | 2013-09-17 | 2018-03-14 | ヴェクタス バイオシステムズ リミテッド | 高血圧及び／又は線維症の処置用組成物 |
-
2014
- 2014-09-17 NO NO14845373A patent/NO3046901T3/no unknown
- 2014-09-17 ES ES14845373.1T patent/ES2655455T3/es active Active
- 2014-09-17 SG SG11201601642WA patent/SG11201601642WA/en unknown
- 2014-09-17 AP AP2016009079A patent/AP2016009079A0/xx unknown
- 2014-09-17 KR KR1020167008664A patent/KR101736416B1/ko active Active
- 2014-09-17 US US15/022,278 patent/US9458093B2/en active Active
- 2014-09-17 RU RU2016112257A patent/RU2635564C2/ru active
- 2014-09-17 DK DK14845373.1T patent/DK3046901T3/en active
- 2014-09-17 CA CA2924356A patent/CA2924356C/en active Active
- 2014-09-17 AU AU2014324078A patent/AU2014324078B2/en active Active
- 2014-09-17 EP EP14845373.1A patent/EP3046901B1/en active Active
- 2014-09-17 UA UAA201602267A patent/UA118111C2/uk unknown
- 2014-09-17 WO PCT/AU2014/000923 patent/WO2015039173A1/en not_active Ceased
- 2014-09-17 PL PL14845373T patent/PL3046901T3/pl unknown
- 2014-09-17 MY MYPI2016000482A patent/MY172557A/en unknown
- 2014-09-17 NZ NZ717927A patent/NZ717927A/en unknown
- 2014-09-17 CN CN201480050979.1A patent/CN105683152B/zh active Active
- 2014-09-17 JP JP2016515425A patent/JP6122548B2/ja active Active
- 2014-09-17 MX MX2016003371A patent/MX368865B/es active IP Right Grant
- 2014-09-17 BR BR112016005601-9A patent/BR112016005601B1/pt active IP Right Grant
-
2016
- 2016-03-14 PH PH12016500497A patent/PH12016500497B1/en unknown
- 2016-03-16 IL IL244621A patent/IL244621A/en active IP Right Grant
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2924356C (en) | Compositions for the treatment of hypertension and/or fibrosis | |
| US20250195526A1 (en) | Pharmaceutical compositions comprising sepiapterin and uses thereof | |
| EA021974B1 (ru) | Противовирусное соединение | |
| EP3680232B1 (en) | Novel anthranilic acid-based compound, and pin1 inhibitor, therapeutic agent for inflammatory diseases and therapeutic agent for cancer that use the same | |
| CA2924353C (en) | Compositions for the treatment of hypertension and/or fibrosis | |
| EP3458448A1 (en) | Methods of using fasn inhibitors | |
| US9181248B2 (en) | [1,2,4]triazolopyridines and their use as phosphodiesterase inhibitors | |
| EP3680233A1 (en) | NOVEL AMIDE COMPOUND, AND Pin1 INHIBITOR, THERAPEUTIC AGENT FOR INFLAMMATORY DISEASES AND THERAPEUTIC AGENT FOR CANCER THAT USE THE SAME | |
| CN106995368B (zh) | 一种非atp竞争性fgfr1抑制剂及其应用 | |
| HK1226324A1 (en) | Compositions for the treatment of hypertension and/or fibrosis | |
| HK1226324B (en) | Compositions for the treatment of hypertension and/or fibrosis | |
| US10183908B2 (en) | Compositions for the treatment of kidney and/or liver disease | |
| JPWO2014030624A1 (ja) | スチルベン誘導体を有効成分として含有する筋緊張性ジストロフィー治療剤 | |
| JP2019089720A (ja) | 化合物又はその薬学的に許容され得る塩、筋形成促進剤、筋萎縮抑制剤、医薬組成物及びｔａｚ活性化剤 | |
| HK1248212A1 (en) | Compositions for the treatment of kidney and/or liver disease | |
| HK1248212B (en) | Compositions for the treatment of kidney and/or liver disease | |
| CN103159650A (zh) | 芳香杂环磺酰胺类化合物的制备及其应用 |